Goldman Sachs Initiates Coverage On BrightSpring Health with Buy Rating, Announces Price Target of $71

BrightSpring Health Services, Inc.

BrightSpring Health Services, Inc.

BTSG

0.00

Goldman Sachs analyst Scott Fidel initiates coverage on BrightSpring Health (NASDAQ: BTSG) with a Buy rating and announces Price Target of $71.